- Home
- NICM vs ATRA Comparison
NICM vs ATRA Comparison
Compare NICM & ATRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NICM | ATRA |
|---|---|---|
| Founded | 1980 | 2012 |
| Country | Canada | United States |
| Employees | 25 | N/A |
| Industry | | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 100.4M | 94.2M |
| IPO Year | N/A | 2014 |
Fundamental Metrics
Financial Performance| Metric | NICM | ATRA |
|---|---|---|
| Price | $5.17 | $9.29 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $13.67 |
| AVG Volume (30 Days) | 4.4K | ★ 27.8K |
| Earning Date | 11-27-2026 | 11-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 122.52 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $120,772,000.00 |
| Revenue This Year | $355.99 | N/A |
| Revenue Next Year | $161.43 | $1,334.59 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $5.00 | $3.92 |
| 52 Week High | $7.00 | $19.15 |
Technical Indicators
Market Signals| Indicator | NICM | ATRA |
|---|---|---|
| Relative Strength Index (RSI) | 29.35 | 50.08 |
| Support Level | N/A | $8.94 |
| Resistance Level | $5.68 | $9.93 |
| Average True Range (ATR) | 0.24 | 0.56 |
| MACD | -0.03 | -0.00 |
| Stochastic Oscillator | 2.35 | 36.14 |
Price Performance
Historical ComparisonAbout NICM Nicola Mining Inc. American Depositary Shares
Nicola Mining Inc is a junior exploration and custom milling company that is engaged in the business of identification, acquisition, and exploration of mineral property interests, together with custom milling partnerships at its Merritt Mill. The company holds interests in various claims at the following properties: the Treasure Mountain Property, New Craigmont Property, and Dominion Creek Property. Its portfolio of producing assets and development projects is mainly composed of copper, gold, and silver properties spread across British Columbia, Canada.
About ATRA Atara Biotherapeutics Inc.
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA3431, and ATA3219.